CD274 and cancer: Immunotherapy analysis showed that the levels of myeloid-derived suppressor cells (MDSC), cancer-associated fibroblasts (CAF), CD274 (PD-L1), and immune exclusion were lower in the high-ratio group compared to the low-ratio MSMB/Epithelial_cells group (Figure 7A).